|
Dr. John W. Hubbard is the Global President of ICON Clinical Research. He has been with ICON since 1999 and has held the following positions: Chief Operating Officer, U.S. Operations and Regional President, ICON Clinical Research, U.S. He was promoted to Global President in March 2007.
John has more than 22 years of experience in pharmaceutical research and development and has held senior management positions at Clinical Studies, Ltd., PAREXEL International Corporation, Hoechst Marion Roussel Pharmaceuticals, and Revlon Health Care.
He received a B.S. in Biopsychology from the University of Santa Clara, a Ph.D. in Cardiovascular Physiology from the University of Tennessee, and was a National Institute of Health (NIH) Postdoctoral Fellow in Cardiovascular Pharmacology at the University of Texas Health Sciences Center. He is a Fellow of the American College of Clinical Pharmacology and a Board Certified Diplomat in Applied Pharmacology by the American Board of Clinical Pharmacology. He has authored or co-authored three book chapters and 76 published articles and abstracts in the areas of cardiovascular/autonomic pharmacology, clinical pharmacology, and drug development. | 